✦ LIBER ✦

Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment

✍ Scribed by Hanno, Abd El- Fatah Fahmy; Mohiedeen, Khaled Mahmoud; Deghedy, Akram; Sayed, Reeham

Book ID: 124117925
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 572 KB
Volume: 15
Category: Article
ISSN: 1687-1979
DOI: 10.1016/j.ajg.2014.04.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lambda Interferon Serum Levels in Patien

Lambda Interferon Serum Levels in Patients with Chronic Hepatitis C Virus Infection According to Their Response to Therapy with Pegylated Interferon and Ribavirin

✍ Torres, Claudio; Brahm, Javier; Venegas, Mauricio 📂 Article 📅 2014 🏛 Mary Ann Liebert 🌐 English ⚖ 138 KB

Serum hs-CRP was correlated with treatme

Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients

✍ Chung-Feng Huang; Ming-Yen Hsieh; Jeng-Fu Yang; Wu-Cheng Chen; Ming-Lun Yeh; Chi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 193 KB

Serum autoantibodies positivity prevalen

Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response

✍ Khairy, Marwa; El-Raziky, Maissa; El-Akel, Wafaa; Abdelbary, Mohamed S.; Khatab, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Superior response to pegylated interfero

Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C

✍ Venessa Pattullo; E. Jenny Heathcote; David K. H. Wong 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 296 KB

Serum B12 levels predict response to tre

Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection

✍ P. Rosenberg; K. Hagen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Response to pegylated interferon alfa-2a

Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4

✍ Hesham El Makhzangy; Gamal Esmat; Mohamed Said; Maissa ElRaziky; Soheir Shouman; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract The safety and efficacy of pegylated interferon (PEG‐IFN) alfa‐2a and ribavirin were studied among patients treated for genotype 4 chronic hepatitis C. Ninety‐five patients with chronic hepatitis C genotype 4 were treated with PEG‐IFN alfa‐2a (180 µg/week) plus ribavirin (≥11 mg/kg/day)